Aizvērt

LV - LV


Please select a country and, if applicable, a language.

Pašārstēšanās ir svarīgs veselības aprūpes pīlārs

… un ir jāpielieto uz pieejamo pierādījumu pamata tāpat kā ārsta parakstīta terapija. Evidence for Self-Medication (EfSM) sniedz kompaktus pārskatus no attiecīgajiem pētījumiem par OTC zālēm un aktīvajām vielām, lai farmaceiti un citi veselības aprūpes speciālisti nodrošinātu pēc iespējas labākus ieteikumus par pašārstēšanos uz pierādījumu bāzes. 

 

Visus EfSM rakstus ir pārskatījuši konsultanti. Tos varat lasīt vācu un angļu valodā, turklāt daudzi no tiem ir pieejami arī citās valodās.

Complex pharmaceutical Traumeel® S (Tr14) improves the resolution of inflammation


Abstract: The resolution of inflammation has to date been explained by the disappearance of inflammatory messenger substances, the production of which is suppressed by non-steroidal anti-inflammatory drugs (NSAIDs). The latest studies, however, show that the resolution of inflammation is an actively controlled process, involving specialised pro-resolving mediators. Their formation is promoted by t ...

Uz rakstu
Autors: Paul M. Jordan un Oliver WerzEFSM: 2025;5:250001DOI: 10.52778/efsm.25.0001Datums: 05.02.2025

How community pharmacists facilitate optimal constipation self-management


Constipation, a common ailment, often finds its first line of management at a community pharmacy. As the relevance of self-medication increases, pharmacists play a pivotal role in patient education, primary consultation, and evidence-based treatment recommendations. A crucial aspect of this role is offering relief while recognizing when to suggest additional medical consultation [1].

Uz rakstu
Autors: Christian Ude, Eric Martin, Dilhan Esen un Daniel PohlEFSM: 2024;4:240053DOI: 10.52778/efsm.24.0053Datums: 21.12.2024

Acetylsalicylic acid 1,000 mg: strong evidence and good tolerability in acute headache management


Headaches are most prevalent in middle age and not only have an immediate impact on the quality of life of those affected but also significantly influence their work and overall productivity. The majority of sufferers manage acute headaches through self-medication. National and international guidelines recommend acetylsalicylic acid (ASA) as a first-line treatment, with the scientific evidence for ...

Uz rakstu
Autors: Jens SeibelEFSM: 2024;4:240051DOI: 10.52778/efsm.24.0051Datums: 17.10.2024

Deciphering the daily disruption of cough: the role of ambroxol in patient recovery and quality of …


Ambroxol is a mucoactive agent which has been widely used to treat acute and chronic respiratory diseases associated with a disturbance of mucus formation and transport. More recent data demonstrated that acute and chronic cough have also significant negative impact on the daily lives of adults and children. This article evaluates the impact of ambroxol on cough recovery speed and quality of life, ...

Uz rakstu
Autors: Heidemarie Graeter, Lara Jagwanth un Anne-Laure TardyEFSM: 10.52778/efsm.24.0045DOI: 10.52778/efsm.24.0045Datums: 16.10.2024

Are all stimulant laxatives the same?  A comparative perspective on bisacodyl, sodium …


Stimulant laxatives, such as bisacodyl, sodium picosulfate (SPS), and senna, are recommended to treat constipation, based on the recent AGA/ACG guideline [1], with different levels of recommendation and evidence. They all stimulate intestinal motility, as well as water and electrolyte secretion, and accelerate intestinal transit time [2, 3]. Herbal laxatives cannot be generalized to be gentler com ...

Uz rakstu
Autors: Maura Corsetti, Anna Lacerda, Ketu Patel un Alèxia AranEFSM: 2024;4:240040DOI: 10.52778/efsm.24.0040Datums: 15.09.2024

EfSM vēstkopa


Reģistrējieties mūsu vēstkopai un saņemiet informāciju par jaunākajām EfSM publikācijām.

Reģistrēties šeit

Izcelts raksts


Ambroxol increases cilia beating in the airways to remove the mucus. A new study has shed light on further details of the signalling pathway responsible for the mucokinetic action.